logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jin Nakahara

keio university school of medicine
H指数:34
被引数:5,939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials

瑞米布利汀与特立氟阿明在复发型多发性硬化中的比较（REMODEL-1和REMODEL-2）：两项随机、III期临床试验

The Lancet
IF88.5
2026-10-230
OAAI
Heinz Wiendl; Robert Bermel; Laura Airas; Tanuja Chitnis; Jin Nakahara; Mitzi Williams; Monika Adamczyk-Sowa; Karolina Piasecka-Stryczynska; Ronald Zielman; Sinead Dunphy; Nicolas Panchaud; Min Cai; Jing Xi; Brett Loop; Wendy Su; Roman Willi; Xavier Montalban
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report

血浆3-<i>O</i>-甲基多巴浓度监测在左旋多巴/卡比多巴注射剂输注治疗优化中的应用：对校正左旋多巴生物利用度的影响：病例报告

Movement Disorders Clinical Practice
IF2.7
2026-09-210
OAAI
Shohei Okusa MD, PhD; Kotaro Okada MD; Yoshihiro Nihei MD, PhD; Risano Sakai; Takeshi Akiyoshi PhD; Tomonori Nukariya MD; Jin Nakahara MD, PhD; Hisakazu Ohtani PhD; Morinobu Seki MD, PhD
Endovascular Therapy for Acute Ischemic Stroke Beyond 24 Hours After Onset: A Nationwide Registry-Based Analysis

发病24小时后急性缺血性卒中的血管内治疗：一项基于全国登记研究的分析

Stroke-Vascular and Interventional Neurology
IF2.8
2026-05-010
PRE
Inui, Ryoma; Tanaka, Kanta; Toyoda, Kazunori; Yoshimura, Sohei; Miwa, Kaori; Yoshie, Tomohide; Miyazaki, Junji; Machida, Toshio; Tsuzuki, Takashi; Morita, Kenichi; Nakahara, Jin; Miyamoto, Yoshihiro; Minematsu, Kazuo; Koga, Masatoshi
Ketone Body Supplementation Exerts Renoprotective Effects Against Adenine-Induced Kidney Injury via OXCT1-Mediated Ketolysis in Mice

酮体补充剂通过OXCT1介导的酮体分解对腺嘌呤诱导的肾脏损伤产生肾保护作用（小鼠）

the faseb journal
IF0
2026-03-090
OA
Shoji Omachi; Sho Sugahara; Junya Horiguchi; Mako Yasuda-Yamahara; Shogo Kuwagata; Kosuke Yamahara; Yuki Tanaka-Sasaki; Shogo Ida; Tetsuro Kusaba; Benjamin D. Humphreys; Kenji Kufukihara; Jin Nakahara; Masami Chin-Kanasaki; Shinji Kume
Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study)

日本真实世界临床环境中视神经脊髓炎谱系障碍患者应用萨他利珠单抗的长期有效性与安全性：一项多中心医疗病历回顾的2.5年最终分析（The SAkuraBeyond Study）

Multiple Sclerosis Journal
IF5
2026-02-240
PRE
Kazuo Fujihara; Noriko Isobe; Katsuichi Miyamoto; Masaaki Niino; Jin Nakahara; Satoshi Hattori; Masami Tanaka; Masayuki Tahara; Akio Suzumura; Kenzo Sakurai; Nobuaki Yoshikura; Kazutaka Shiomi; Hirofumi Ochi; Eiichiro Nagata; Kazushi Deguchi; Yuji Tomizawa; Katsuhisa Yamashita; Tadashi Nagatsuka; Hiroki Adachi; Ichiro Nakashima
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis

首次使用奥法木单抗作为一线治疗新近诊断且未接受过治疗的复发型多发性硬化患者的6年安全性与有效性结果

Multiple Sclerosis and Related Disorders
IF2.9
2025-11-250
OAAI
Stephen L. Hauser; Mark S. Freedman; Jin Nakahara; David Paling; Jérôme de Seze; Jun Li; Anil Abeyewickreme; Min Wu; Roseanne Sullivan; Gabriel Pardo; Xavier Montalban; Heinz Wiendl
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

日本视神经脊髓炎谱系障碍患者中萨他利珠单抗的安全性及有效性：一项为期30个月的市场后监测中期分析

Neurology and Therapy
IF4.8
2025-09-260
OAAI
Takashi Yamamura; Noriko Isobe; Izumi Kawachi; Chiyoko Nohara; Yusei Miyazaki; Minami Tomita; Yuta Kamei; Katsuhisa Yamashita; Jin Nakahara; Ichiro Nakashima; Kazuo Fujihara
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis

奥法木单抗在复发型多发性硬化患者中的五年安全性和有效性结局

Neurology and Therapy
IF4.8
2025-07-130
OAAI
Stephen L. Hauser; Jeffrey A. Cohen; Jérôme de Sèze; Sven G. Meuth; Paul S. Giacomini; Jin Nakahara; Celia Oreja-Guevara; Derrick Robertson; Sibyl Wray; Alit Bhatt; Xixi Hu; Jing Xi; Rebecca Piccolo; Valentine Jehl; Roseanne Sullivan; Ibolya Boer; Heinz Wiendl; Ludwig Kappos
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review

日本真实世界临床环境中萨特拉利珠单抗的有效性：视神经脊髓炎谱系障碍中的白细胞介素-6受体抑制：一项多中心医疗病历回顾的六个月中期分析

MULTIPLE SCLEROSIS AND RELATED DISORDERS
IF2.9
2025-06-010
PRE
Fujihara, Kazuo; Isobe, Noriko; Miyamoto, Katsuichi; Niino, Masaaki; Nakahara, Jin; Hattori, Satoshi; Yamamoto, Mamoru; Kawachii, Izumi; Matsui, Naoko; Nohara, Chiyoko; Kokubun, Norito; Chihara, Norio; Misu, Tatsuro; Okada, Kazumasa; Yamashita, Katsuhisa; Nagatsuka, Tadashi; Adachi, Hiroki; Nakashima, Ichiro
Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: Post hoc analysis of the EOS individual participant data

先前抗血小板治疗后静脉注射阿替普酶治疗不明卒中的疗效和安全性: EOS个体参与者数据的事后分析

INTERNATIONAL JOURNAL OF STROKE
IF8.7
2025-02-270
PRE
Shiomi, Yuma; Miwa, Kaori; Jensen, Maerit; Inoue, Manabu; Yoshimura, Sohei; Kamogawa, Naruhiko; Fukuda-Doi, Mayumi; Ma, Henry; Ringleb, Peter; Wu, Ona; Schwamm, Lee H.; Davis, Stephen M.; Donnan, Geoffrey A.; Gerloff, Christian; Nakahara, Jin; Toyoda, Kazunori; Thomalla, Goetz; Koga, Masatoshi; Evaluation Unknown Onset Stroke Thrombolysis Trials EOS Investigators

研究方向

暂未获取到该数据
N
Norihiro Suzuki
H 指数:78论文数:1,339被引数:2.7万
T
Tsubasa Takizawa
H 指数:24论文数:118被引数:2,004
D
Daisuke Ito
H 指数:51论文数:336被引数:1.3万
M
Morinobu Seki
H 指数:19论文数:79被引数:1,669
T
Toshiki Tezuka
H 指数:10论文数:61被引数:410
H 指数:0论文数:41被引数:332
H
Hideyuki Okano
H 指数:145论文数:1,788被引数:8.6万
Ḱ
Ḱazunori Toyoda
H 指数:70论文数:1,036被引数:2.5万
K
Keiko Ihara
H 指数:8论文数:57被引数:451
M
Mamoru Shibata
H 指数:33论文数:145被引数:3,582